A novel docking site on Mediator is critical for activation by VP16 in mammalian cells

AUTOR(ES)

Mittler, Gerhard

FONTE

Oxford University Press

RESUMO

ARC92/ACID1 was identified as a novel specific target of the herpes simplex transactivator VP16 using an affinity purification procedure. Characterization of the protein revealed tight interactions with human Mediator mediated through a von Willebrand type A domain. ARC92/ACID1 further contains a novel activator-interacting domain (ACID), which it shares with at least one other human gene termed PTOV1/ACID2. The structure of ARC92/ACID1 is of ancient origin but is conserved in mammals and in selected higher eukaryotes. A subpopulation of Mediator is associated with ARC92/ACID1, which is specifically required for VP16 activation both in vitro and in mammalian cells, but is dispensable for other activators such as SP1. Despite many known targets of VP16, ARC92/ACID1 appears to impose a critical control on transcription activation by VP16 in mammalian cells.

Documentos Relacionados

• VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells.
• An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP
• A synergistic increase in potency of a multimerized VP16 transcriptional activation domain.
• The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator
• Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.